Medical University of Vienna

🇦🇹Austria

Country: 🇦🇹Austria

Ownership: Private

Established: 1365-01-01

Employees: 1K

Market Cap: -

Website: http://www.meduniwien.ac.at

Clinical Trials

Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.

Phase 4

Completed

Conditions: Steatosis, Liver
Type2 Diabetes

Interventions: Drug: Exenatide
Drug: Exenatide matching Placebo
Drug: Dapagliflozin

First Posted Date: 2017-01-02

Last Posted Date: 2022-04-15

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 34

Registration Number: NCT03007329

Locations: 🇦🇹
Abt. für Endokrinologie & Stoffwechsel, Univ. Klin f. Innere Medizin III, Wien, Austria

Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus

Completed

Conditions: PreTerm Birth
Diabetes, Gestational
Glucocorticoids
Insulin Sensitivity
Glucose Intolerance During Pregnancy

First Posted Date: 2017-01-02

Last Posted Date: 2019-03-13

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 36

Registration Number: NCT03007186

Locations: 🇦🇹
AKH (General Hospital of) Vienna, Vienna, Austria

Oral Probiotics to Reduce Vaginal Group B Streptococcal Colonization in Late Pregnancy

Not Applicable

Completed

Conditions: Pregnancy Complications
Vaginal Infection
Neonatal Sepsis
GBS

Interventions: Other: Placebo
Dietary Supplement: Astarte® (HSO Health Care GmbH, Vienna, Austria)

First Posted Date: 2017-01-02

Last Posted Date: 2020-12-08

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 1058

Registration Number: NCT03008421

Locations: 🇦🇹
Medical University of Vienna, Vienna General Hospital, Department of Obstetrics and Gynecology, Vienna, Austria

EXtendedAnalysis for Cancer Treatment

Not Applicable

Conditions: Malignant Solid Tumor

Interventions: Other: individual therapy

First Posted Date: 2016-12-21

Last Posted Date: 2016-12-21

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 55

Registration Number: NCT02999750

Locations: 🇦🇹
AKH Vienna, Vienna, Austria

Optimal Growth of Preterm Infants With Growth Restriction

Not Applicable

Withdrawn

Conditions: Adiposity
Growth Failure
Diabetes
Neurologic Deficits

Interventions: Other: SGA-standard nutrients
Other: IUGR-standard nutrients
Dietary Supplement: SGA-enhanced nutrients
Dietary Supplement: IUGR-enhanced nutrients

First Posted Date: 2016-12-21

Last Posted Date: 2019-03-21

Lead Sponsor: Medical University of Vienna

Registration Number: NCT02999945

Brain Glucose Metabolism During Transcranial Direct Current Stimulation

Not Applicable

Completed

Conditions: Depression

Interventions: Other: transcranial direct current stimulation

First Posted Date: 2016-12-21

Last Posted Date: 2018-01-16

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 15

Registration Number: NCT02999607

Locations: 🇦🇹
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria

Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone

Completed

Conditions: Preterm Birth

First Posted Date: 2016-12-15

Last Posted Date: 2017-05-30

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 140

Registration Number: NCT02993744

Locations: 🇦🇹
General Hospital Vienna, Vienna, Austria

Investigation of Antidepressant Efficacy of Oral Ketamine Treatment

Phase 2

Conditions: Major Depressive Episode

Interventions: Drug: Midazolam Hydrochloride
Drug: Ketamine

First Posted Date: 2016-12-14

Last Posted Date: 2019-09-03

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 60

Registration Number: NCT02992496

Locations: 🇦🇹
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria

Influence of Three Different Formulations of Lachrymal Substitutes on Tear Film Thickness and Other Signs and Symptoms in Patients With Moderate to Severe Dry Eye Syndrome

Phase 4

Completed

Conditions: Dry Eye Syndromes

Interventions: Device: Thealoz Duo Eye Drops
Device: Systane Ultra Eye Drops
Device: Optive Eye Drops

First Posted Date: 2016-12-08

Last Posted Date: 2019-08-20

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 120

Registration Number: NCT02986750

Locations: 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye Syndrome

Not Applicable

Completed

Conditions: Dry Eye Syndromes

Interventions: Device: Thealoz Duo eye drops and Thealoz Duo gel
Device: Thealoz Duo gel

First Posted Date: 2016-12-02

Last Posted Date: 2019-08-22

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 45

Registration Number: NCT02980913

Locations: 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy